Chicago-based Advanced Life Sciences to be showcased at prestigious equity conferences

Woodridge, Ill, October 1, 2002 - Advanced Life Sciences, Inc. (ALS) will be participating in two highly prestigious equity conferences, both taking place today, announced Michael T. Flavin, Ph.D., ALS's Chief Executive Officer.

Biotechnology Industry Organization (BIO) selected ALS as one of the biotechnology companies who will be showcased at BIO VentureForum 2002 at the Palace Hotel in San Francisco today and tomorrow. An advisor panel of 41 healthcare venture firms selected ALS from more than 350 applicants. The presenting companies represent 25 states and six countries.

In addition, William Blair & Co. has invited ALS to present at that company's Fifth Annual Private Equity Conference at the Four Seasons Hotel in Chicago. William Blair & Company anticipates that representatives more than 200 private equity firms will attend.

"Advanced Life Sciences acknowledges the recognition of having been chosen to present as these two elite conferences," said Flavin. "We believe that our formula of securing the best products for investigation, the smartest people and the most efficient process is paying off for our company and our investors.

Advanced Life Sciences is a privately held biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer, and inflammation using its platform in natural products and chemical proteomics coupled with expertise in drug development. (